Open for inclusion

Rituximab with or without Ibrutinib for untreated patients with advanced follicular lymphoma in need of therapy. A randomized double-blinded Phase II trial

Cancer type: Lymphoma

Phase: II

Principal Investigator: Østenstad Bjørn

Keywords: Norway, Oslo, Adult patients with follicular lymphoma

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02451111?term=2015-001487-19&rank=1